What is the price per share on the Ingevity (NGVT) director’s stock grant?

The reported transaction price per share on the 1,904-share grant is $0.0000. This indicates the award was made at no cash cost to director Francis David Segal, consistent with stock-based compensation granted under Ingevity Corporation’s 2025 Omnibus Incentive Plan.

Ingevity (NGVT) director awarded 1,904 RSUs vesting in 2027

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Segal Francis David reported acquisition or exercise transactions in this Form 4 filing.

Ingevity Corp director Francis David Segal reported receiving an equity award under the company’s 2025 Omnibus Incentive Plan. He was granted 1,904 shares of Common Stock at no cost, structured as restricted stock units that will vest in full on April 30, 2027. Following this grant, he directly holds 8,284 shares of Ingevity common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Segal Francis David

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,904	$0.00	--

Holdings After Transaction: Common Stock — 8,284 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares granted: 1,904 shares Grant price: $0.0000 per share Post-grant holdings: 8,284 shares +1 more

4 metrics

Shares granted 1,904 shares Restricted stock unit award of Common Stock

Grant price $0.0000 per share Equity compensation grant to director

Post-grant holdings 8,284 shares Common Stock directly owned after transaction

Vesting date April 30, 2027 Restricted stock units vest in full on this date

Key Terms

restricted stock units, 2025 Omnibus Incentive Plan, Common Stock, Grant, award, or other acquisition

4 terms

restricted stock units financial

"Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2025 Omnibus Incentive Plan financial

"pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full"

An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.

Common Stock financial

"security_title: Common Stock with 1,904.0000 shares granted at 0.0000 price"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

05/01/2026 - 06:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Segal Francis David

(Last)

(First)

(Middle)

C/O INGEVITY CORPORATION

4920 O'HEAR AVE, SUITE 400

(Street)

NORTH CHARLESTON

SOUTH CAROLINA

29405

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/30/2026		A		1,904⁽¹⁾	A	$0	8,284	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full on April 30, 2027.

Remarks:

	Francis David Segal By: Mavis G. Huger as Attorney-in-Fact	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Ingevity (NGVT) disclose in this Form 4?

Ingevity disclosed that director Francis David Segal received an equity award of 1,904 shares of Common Stock at a price of $0.00 per share. The award was granted as restricted stock units under Ingevity’s 2025 Omnibus Incentive Plan and represents a compensation-related acquisition.

How many Ingevity (NGVT) shares were granted to Francis David Segal?

Francis David Segal was granted 1,904 shares of Ingevity Common Stock. These shares are in the form of restricted stock units and were awarded at no cash cost to him. The grant increases his directly held position reported in the filing to a total of 8,284 shares.

When do the restricted stock units granted by Ingevity (NGVT) vest?

The restricted stock units granted to Francis David Segal will vest in full on April 30, 2027. Until that vesting date, the award remains subject to the plan’s conditions. Upon vesting, the units are expected to convert into shares of Ingevity Common Stock for the director.

How many Ingevity (NGVT) shares does Francis David Segal hold after the grant?

After the 1,904-share grant, Francis David Segal is reported to directly own 8,284 shares of Ingevity Common Stock. This total reflects his holdings immediately following the compensation-related acquisition disclosed, providing context for his equity stake as a company director.

What plan governs the Ingevity (NGVT) restricted stock unit grant?

The restricted stock unit grant to Francis David Segal was made under Ingevity Corporation’s 2025 Omnibus Incentive Plan. This plan authorizes equity-based awards such as restricted stock units for eligible participants, with this specific grant scheduled to vest entirely on April 30, 2027.